Connect your AI

United Therapeutics UTHR Interest Expense

Interest Expense at other companies

Tenet HealthcareTHC

$205M+0.5%

Johnson & JohnsonJNJ

$281M-8.8%

InsmedINSM

$20.08M-6.9%

LQD

Liquidia CorporationLQDA

$6.49M+39.1%

Theravance BiopharmaTBPH

$582K-9.5%

AmgenAMGN

——

Other financials

Income statement

Revenue$781.5M-1.6%

Gross profit$648.1M-7.7%

Operating income$325.8M-14.9%

Net income$274.9M-14.7%

EPS (diluted)$5.82-12.2%

Balance sheet

Cash & equivalents$1.3B-32.6%

Total debt$12.2M—

Total equity$5.9B-13.3%

Total assets$6.7B-13.3%

Cash flow

Operating cash flow$463.3M+0.5%

CapEx$100.8M+34.6%

Free cash flow$362.5M-6.2%

Valuation

Market cap$26.32B+95.7%

P/E20.4×+9.6×

P/S8.3×+3.9×

Profitability

Gross margin86.6%-2.4pp

Operating margin45.3%-1.6pp

Net margin40.6%+0.2pp

FCF margin32.1%-5.6pp

Returns & leverage

Return on equity20.3%+0.3pp

Debt / equity0×—

Current ratio4.8×-0.7×

Where this comes from

Reported directly by United Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:InterestExpenseNonoperating.

The official record: United Therapeutics’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about United Therapeutics's interest expense.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is United Therapeutics's interest expense?: United Therapeutics (UTHR) reported interest expense of $3M in Q1 2026.
How has United Therapeutics's interest expense changed year-over-year?: United Therapeutics's interest expense decreased by 50.8% year-over-year, from $6.1M to $3M.
What is the long-term trend for United Therapeutics's interest expense?: Over 4 years (2021 to 2025), United Therapeutics's interest expense has grown at a 1.2% compound annual growth rate (CAGR), from $18.6M to $19.5M.
What does interest expense mean?: Cost of borrowing — interest paid or accrued on bonds, bank loans, credit facilities, finance leases, and other debt obligations.